Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Shijiazhuang No.4 Pharmaceutical Co., Ltd., commonly referred to as Shijiazhuang No.4 Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shijiazhuang, China. Established in 1956, the company has evolved significantly, focusing on the research, development, and manufacturing of a diverse range of pharmaceutical products, including APIs (Active Pharmaceutical Ingredients) and finished dosage forms. With a strong presence in both domestic and international markets, Shijiazhuang No.4 Pharma is recognised for its commitment to quality and innovation. The company’s core offerings include a variety of therapeutic agents, particularly in the fields of cardiovascular and anti-infective medications, distinguished by their high efficacy and safety profiles. Over the years, Shijiazhuang No.4 Pharma has achieved notable milestones, solidifying its position as a trusted supplier in the global pharmaceutical landscape.
DitchCarbon Score
How does Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shijiazhuang No.4 Pharmaceutical Co., Ltd.'s reported carbon emissions
Shijiazhuang No.4 Pharmaceutical Co., Ltd., headquartered in China, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. As Shijiazhuang No.4 Pharmaceutical Co., Ltd. continues to operate, it may consider establishing clear climate commitments and reduction strategies to align with industry standards and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
